Skip to content
AfDB
-
AfDB invests US$16.6M in Egypt’s Minapharm for biosimilar production
The initiative is projected to generate €446 million (US$ 493.57 million) in local value and foster €137 million (US$151.61 million) in domestic business connections, with 40% of the benefits accruing to small and medium-sized enterprises.